133 related articles for article (PubMed ID: 15911136)
1. The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm.
Zhang ZJ; Jiang XL; Zhang SE; Hough CJ; Li H; Chen JG; Zhen XC
Neurosci Lett; 2005 Jul 1-8; 382(1-2):134-8. PubMed ID: 15911136
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
3. The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959.
Zhen X; Goswami S; Friedman E
Pharmacol Biochem Behav; 2005 Apr; 80(4):597-601. PubMed ID: 15820529
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-linked novel D(1) dopamine receptor facilitates long-term depression in rat hippocampal CA1 synapses.
Liu J; Wang W; Wang F; Cai F; Hu ZL; Yang YJ; Chen J; Chen JG
Neuropharmacology; 2009 Aug; 57(2):164-71. PubMed ID: 19465033
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action.
Yu Y; Wang JR; Sun PH; Guo Y; Zhang ZJ; Jin GZ; Zhen X
J Neurochem; 2008 Feb; 104(4):946-56. PubMed ID: 18005341
[TBL] [Abstract][Full Text] [Related]
6. Activation of phosphatidylinositol-linked novel D1 dopamine receptors inhibits high-voltage-activated Ca2+ currents in primary cultured striatal neurons.
Ma LQ; Liu C; Wang F; Xie N; Gu J; Fu H; Wang JH; Cai F; Liu J; Chen JG
J Neurophysiol; 2009 May; 101(5):2230-8. PubMed ID: 19225177
[TBL] [Abstract][Full Text] [Related]
7. Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro.
Chu HY; Yang Z; Zhao B; Jin GZ; Hu GY; Zhen X
Brain Res; 2010 Jul; 1343():20-7. PubMed ID: 20420815
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Ca2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons.
Ming Y; Zhang H; Long L; Wang F; Chen J; Zhen X
J Neurochem; 2006 Aug; 98(4):1316-23. PubMed ID: 16771826
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
[TBL] [Abstract][Full Text] [Related]
11. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
Desai RI; Terry P; Katz JL
Pharmacol Biochem Behav; 2005 Aug; 81(4):843-8. PubMed ID: 16000217
[TBL] [Abstract][Full Text] [Related]
13. Effects of pergolide on sensorimotor gating of the startle reflex in rats.
Swerdlow NR; Platten A; Shoemaker J; Pitcher L; Auerbach P
Psychopharmacology (Berl); 2001 Nov; 158(3):230-40. PubMed ID: 11713612
[TBL] [Abstract][Full Text] [Related]
14. SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain.
Panchalingam S; Undie AS
Neuropharmacology; 2001 May; 40(6):826-37. PubMed ID: 11369036
[TBL] [Abstract][Full Text] [Related]
15. Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum.
Kuroiwa M; Bateup HS; Shuto T; Higashi H; Tanaka M; Nishi A
J Neurochem; 2008 Nov; 107(4):1014-26. PubMed ID: 18823371
[TBL] [Abstract][Full Text] [Related]
16. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
17. Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat.
Koch M; Hauber W
Behav Pharmacol; 1998 Feb; 9(1):23-9. PubMed ID: 9832945
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice.
Ralph RJ; Caine SB
Psychopharmacology (Berl); 2007 Apr; 191(3):731-9. PubMed ID: 17019570
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
20. Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
Zhang H; Ma L; Wang F; Chen J; Zhen X
Neuropharmacology; 2007 Jul; 53(1):125-33. PubMed ID: 17553535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
